Cargando…

Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis

Detalles Bibliográficos
Autores principales:	Kennedy, Lindsey, Alpini, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073729/ https://www.ncbi.nlm.nih.gov/pubmed/35131175 http://dx.doi.org/10.1016/j.jcmgh.2022.01.009

Ejemplares similares

Current Therapeutics in Primary Sclerosing Cholangitis
por: Tan, Natassia, et al.
Publicado: (2023)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Primary Sclerosing Cholangitis–Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity
por: Kamp, Eline J.C.A., et al.
Publicado: (2021)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2(−/−) mice and human primary sclerosing cholangitis
por: Meng, Fanyin, et al.
Publicado: (2018)

Protective potential of the gallbladder in primary sclerosing cholangitis
por: Cazzagon, Nora, et al.
Publicado: (2022)

Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management
por: Kumar, Aditi, et al.
Publicado: (2016)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Primary sclerosing cholangitis and pregnancy
por: Kammeijer, Casper Q., et al.
Publicado: (2011)

An Overview on Primary Sclerosing Cholangitis
por: Vlăduţ, Cătălina, et al.
Publicado: (2020)

Endothelin Signaling Mediates Biliary-Endothelial Crosstalk in Primary Sclerosing Cholangitis
por: Yin, Chunyue
Publicado: (2023)

Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2(−/−) mouse model of primary sclerosing cholangitis (PSC)
por: Zhou, Tianhao, et al.
Publicado: (2019)

FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2(−/−) Mouse Model of Primary Sclerosing Cholangitis
por: O’Brien, April, et al.
Publicado: (2022)

Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value
por: Li, Zhen-Jiao, et al.
Publicado: (2022)

Nivolumab-related Sclerosing Cholangitis in Gastric Cancer
por: Motoo, Yoshiharu
Publicado: (2019)

Emerging Therapeutic Strategies in The Fight Against Primary Biliary Cholangitis
por: Medford, Abigail, et al.
Publicado: (2023)

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
por: Kim, Kwang Woo, et al.
Publicado: (2023)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Treatment of primary sclerosing cholangitis in children
por: Laborda, Trevor J, et al.
Publicado: (2019)

Diagnosing Primary Sclerosing Cholangitis in Children
por: Seerat, Iqtadar, et al.
Publicado: (2020)

Role of Endoscopy in Primary Sclerosing Cholangitis
por: Bhat, Purnima, et al.
Publicado: (2021)

Primary sclerosing cholangitis and the path to translation
por: Váncza, Lóránd, et al.
Publicado: (2023)

Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
por: Park, Yong Eun
Publicado: (2022)

Long-Term Follow-Up into Adulthood of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis
por: Hercun, Julian, et al.
Publicado: (2022)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Sclerosing Cholangitis: Palliative Surgery or Transplantation?
por: Cameron, John L.
Publicado: (1992)

Primary sclerosing cholangitis – The arteriosclerosis of the bile duct?
por: Fickert, Peter, et al.
Publicado: (2007)

The best approach for diagnosing primary sclerosing cholangitis
por: Andraus, Wellington, et al.
Publicado: (2011)

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis
por: Tabibian, James H., et al.
Publicado: (2013)

Primary sclerosing cholangitis: diagnostic and management challenges
por: Sirpal, Sanjeev, et al.
Publicado: (2017)

Neonatal cholestasis due to primary sclerosing cholangitis
por: Shetty, Naman Sadanand, et al.
Publicado: (2016)

Pathogenesis and clinical spectrum of primary sclerosing cholangitis
por: Gidwaney, Neelam G, et al.
Publicado: (2017)

Role of endoscopy in the management of primary sclerosing cholangitis
por: Marya, Neil Bharat, et al.
Publicado: (2019)

Geoepidemiologic variation in outcomes of primary sclerosing cholangitis
por: Mehta, Tej I, et al.
Publicado: (2020)

An update on treatment options for primary sclerosing cholangitis
por: Iravani, Shahrokh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ac5oi79oh4jf0lhpqtnb766v4i